JPMorgan Upgrades ResMed (RMD) to Overweight
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $198.99 -1.86%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE
JPMorgan upgraded ResMed (NYSE: RMD) from Neutral to Overweight.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $34.11 yesterday.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $34.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Morgan Stanley (MS) to Buy
- BofA Securities Upgrades ERock Inc (EROC) to Buy
- RBC Capital Downgrades ResMed (RMD) to Sector Perform
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
